Growth Metrics

Pacific Biosciences Of California (PACB) EBITDA Margin Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -343.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -178.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 487.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -283.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 72.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1,505.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -184.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -3,846.00
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn 19,507.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 19,507.00
Dec 31, 2025 21,270.00
Sep 30, 2025 14,224.00
Jun 30, 2025 9,944.00
Mar 31, 2025 -89,221.00
Dec 31, 2024 19,873.00
Jun 30, 2024 -34,766.00
Mar 31, 2024 9,878.00
Dec 31, 2023 -41,304.00
Sep 30, 2023 635.00
Jun 30, 2023 -1,445.00
Mar 31, 2023 -22,721.00
Dec 31, 2022 -30,269.00
Sep 30, 2022 -10,779.00
Jun 30, 2022 -10,531.00
Mar 31, 2022 -7,035.00
Dec 31, 2021 -3,778.00
Jun 30, 2021 -2,985.00
Mar 31, 2021 -17,666.00
Dec 31, 2020 35,941.00
Sep 30, 2020 -3,143.00
Jun 30, 2020 -665.00
Mar 31, 2020 10,408.00
Dec 31, 2019 7,371.00
Sep 30, 2019 -6,316.00
Jun 30, 2019 -1,074.00
Mar 31, 2019 -8,344.00
Dec 31, 2018 -15,388.00
Sep 30, 2018 -15,099.00
Jun 30, 2018 -5,648.00
Mar 31, 2018 -1,062.00
Dec 31, 2017 2,895.00
Sep 30, 2017 -4,894.00
Jun 30, 2017 3,999.00
Mar 31, 2017 6,636.00
Dec 31, 2016 11,456.00
Sep 30, 2016 20,613.00
Jun 30, 2016 24,958.00
Mar 31, 2016 27,776.00
Dec 31, 2015 36,534.00
Sep 30, 2015 83,213.00
Jun 30, 2015 26,137.00
Mar 31, 2015 15,969.00
Dec 31, 2014 -4,364.00
Sep 30, 2014 25,557.00
Jun 30, 2014 1.14 Mn
Mar 31, 2014 1.27 Mn
Dec 31, 2013 1.29 Mn
Sep 30, 2013 1.82 Mn
Jun 30, 2013 485,606.00